DEPARTMENT OF INTERNAL MEDICINE I, UNIVERSITY MEDICAL CENTER OF THE JOHANNES GUTENBERG-UNIVERSITY MAINZ (UMCU)
The Department of Internal Medicine I of the University Medical Center Mainz (Germany) combines the expertise of the specialties Gastroenterology, Hepatology, Endocrinology, Diabetology and Nutrition Medicine, Nephrology, Rheumatology and Infectious diseases with a large and long standing research focus on metabolic diseases and liver cirrhosis. Within the Unit of Hepatology, we are involved in experimental, translational as well as clinical research with the aim to identify new biomarkers and therapies for chronic liver diseases, especially steatotic liver disease (SLD) as well as liver cirrhosis and portal hypertension.
Our department leads the activities in WP2 in conducting retrospective and prospective analyses for the identification of long-term outcomes (LOVE study) and new biomarkers with the development of an AI-based digital tool.
TEAM MEMBERS
Christian Labenz
Christian Labenz is the head of Hepatology subsection and the Cirrhosis Center Mainz at the University Medical Center Mainz. His research is focused on fibrosis screening, SLD and liver cirrhosis (portal hypertension and hepatic encephalopathy). He he will support WP2 of the LIVERAIM project.
Jörn M. Schattenberg
Jörn M. Schattenberg is Full Professor of Medicine and Chair of the Department of Internal Medicine II at the Saarland University. He is a key opinion leader and expert in the field of SLD and MASLD. He belongs to the core team of LIVERAIM, and he will lead WP2.
ALL THE CONSORTIUM